SFPM VIRTUAL MONTHLY SEMINARS

The Functional Precision Medicine Seminar, brought to you by the Members of SFPM, is a monthly series dedicated to showcasing advances in functional assays and their application in oncology precision medicine

Functional assays are in the truest sense precision medicine; matching a patient to a drug by directly testing their live tissue. The hypothesis is simple, yet in a personalized healthcare approach dominated by population scale genomics, the utilization of functional assays is limited. There exists a great opportunity to expand precision medicine beyond genomics, ultimately bringing better treatment options and the potential for greater outcomes to patients in need.

Bringing together a unique mix of pharmaceutical, academic and technology leaders, the series is must attend for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

Through guest speakers, interactive panel discussions and Q&A sessions, the series will focus on these key topics:

  • Demonstrating the clinical utility of functional precision medicine testing
  • Implementing functional testing in precision medicine clinical trials
  • Accelerating the application of functional testing
  • Addressing stakeholder, educational and investment challenges for functional precision medicine

  Become a Member   Register for Seminar


Zoom Information

URL:  https://dfci.zoom.us

Meeting ID: 936 9981 1786
Password: 351904

If joining by phone:

  • +1 312 626 6799 US (Chicago)
  • +1 929 205 6099 US (New York)
  • +1 301 715 8592 US (Germantown)
  • +1 346 248 7799 US (Houston)
  • +1 669 900 6833 US (San Jose)
  • +1 253 215 8782 US (Tacoma)

  Register for Seminar


Upcoming Meetings

September 9th, 2020 | 11:00 AM EST

Lawrence Boise, PhD - Emory University


"Functional and phenotypic analysis of venetoclax sensitivity in multiple myeloma."

Olli Kallioniemi - Karolinska Institute


" - Functional precision cancer medicine: molecular insights and clinical implementation in AML and beyond"

Past Meetings


August 12th, 2020 | 11:00 AM EST

Dr. Zenz Thorsten - University of Zurich


“Drug-perturbation-based stratification of blood cancer”

Dr. Hervé Tiriac - UCSD Moores Cancer Center


"Pancreatic Cancer Patient-Derived Organoids as a Tool for Personalized Medicine"

July 8th, 2020 | 11:00 AM EST

Caroline Heckman, PhD, Research Director, Institute for Molecular Medicine, Finland


“Predicting drug combination efficacy in hematological malignancies by multi-parametric functional analysis”

Gregory Vladimer, PhD, CSO, Allcyte


"High content microscopy of primary patient material and AI in translational research and precision medicine"